These tenbagger stocks are well liked by analysts and may rally more
CNBC Pro screened for stocks that have returned more than 1,000% in the past decade — and could still have sizeable upsides ahead.
Stay updated with breaking news from Repligen Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CNBC Pro screened for stocks that have returned more than 1,000% in the past decade — and could still have sizeable upsides ahead.
Operator: Good day, ladies and gentlemen, and welcome to Repligen’s 2023 Third Quarter Earnings Conference Call. My name is Keith, and I will be your coordinator.
Life sciences company Repligen Corp. (RGEN) announced Tuesday third-quarter net income of $18.17 million or $0.32 per share, sharply down from $40.41 million or $0.
By Ben Glickman Shares of Repligen Corp. rose after the company logged an unexpected profit in the third quarter. The stock was up 19% to $135.64 in Tuesday...
/PRNewswire/ -- The life science and chemical instrumentation market size is expected to grow by USD 14.94 billion from 2021 to 2026. In addition, the momentum...